169 related articles for article (PubMed ID: 37132268)
1. Baseline and early digital [ 18 F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study.
Vuijk FA; Feshtali Shahbazi S; Noortman WA; van Velden FHP; Dibbets-Schneider P; Marinelli AWKS; Neijenhuis PA; Schmitz R; Ghariq E; Velema LA; Peters FP; Smit F; Peeters KCMJ; Temmink SJD; Crobach SALP; Putter H; Vahrmeijer AL; Hilling DE; de Geus-Oei LF
Nucl Med Commun; 2023 Jul; 44(7):613-621. PubMed ID: 37132268
[TBL] [Abstract][Full Text] [Related]
2. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation.
Schurink NW; Min LA; Berbee M; van Elmpt W; van Griethuysen JJM; Bakers FCH; Roberti S; van Kranen SR; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2020 May; 30(5):2945-2954. PubMed ID: 32034488
[TBL] [Abstract][Full Text] [Related]
3. The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review.
Joye I; Deroose CM; Vandecaveye V; Haustermans K
Radiother Oncol; 2014 Nov; 113(2):158-65. PubMed ID: 25483833
[TBL] [Abstract][Full Text] [Related]
4. Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer.
Schurink NW; van Kranen SR; Berbee M; van Elmpt W; Bakers FCH; Roberti S; van Griethuysen JJM; Min LA; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2021 Sep; 31(9):7031-7038. PubMed ID: 33569624
[TBL] [Abstract][Full Text] [Related]
5. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
[TBL] [Abstract][Full Text] [Related]
6. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT.
Ippolito D; Monguzzi L; Guerra L; Deponti E; Gardani G; Messa C; Sironi S
Abdom Imaging; 2012 Dec; 37(6):1032-40. PubMed ID: 22270580
[TBL] [Abstract][Full Text] [Related]
7.
Avallone A; Aloj L; Pecori B; Caracò C; De Stefano A; Tatangelo F; Silvestro L; Granata V; Bianco F; Romano C; Di Gennaro F; Budillon A; Petrillo A; Muto P; Botti G; Delrio P; Lastoria S
J Nucl Med; 2019 Nov; 60(11):1560-1568. PubMed ID: 30877175
[TBL] [Abstract][Full Text] [Related]
8. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
[TBL] [Abstract][Full Text] [Related]
9. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M
Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275
[TBL] [Abstract][Full Text] [Related]
10. Predicting locally advanced rectal cancer response to neoadjuvant therapy with
Giannini V; Mazzetti S; Bertotto I; Chiarenza C; Cauda S; Delmastro E; Bracco C; Di Dia A; Leone F; Medico E; Pisacane A; Ribero D; Stasi M; Regge D
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):878-888. PubMed ID: 30637502
[TBL] [Abstract][Full Text] [Related]
11. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology.
Koç M; Kaya GÇ; Demir Y; Sürücü E; Sarioğlu S; Obuz F; Öztop İ; Görken İB; Sökmen S
Nucl Med Commun; 2015 Sep; 36(9):898-907. PubMed ID: 25969176
[TBL] [Abstract][Full Text] [Related]
12. Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
Dos Anjos DA; Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; de Sousa JB; Buchpiguel CA
Dis Colon Rectum; 2016 Sep; 59(9):805-12. PubMed ID: 27505108
[TBL] [Abstract][Full Text] [Related]
13. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH
Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
15. (18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Nishimura J; Hasegawa J; Ogawa Y; Miwa H; Uemura M; Haraguchi N; Hata T; Yamamoto H; Takemasa I; Mizushima T; Nezu R; Doki Y; Mori M
Surg Today; 2016 Oct; 46(10):1152-8. PubMed ID: 26711129
[TBL] [Abstract][Full Text] [Related]
16. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
[TBL] [Abstract][Full Text] [Related]
17. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.
Song I; Kim SH; Lee SJ; Choi JY; Kim MJ; Rhim H
Br J Radiol; 2012 May; 85(1013):577-86. PubMed ID: 21343320
[TBL] [Abstract][Full Text] [Related]
18. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
[TBL] [Abstract][Full Text] [Related]
19. Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial.
Guido A; Cuicchi D; Castellucci P; Cellini F; Di Fabio F; Llimpe FLR; Strigari L; Buwenge M; Cilla S; Deodato F; Macchia G; Galietta E; Golfieri R; Ardizzoni A; Zagari RM; Fanti S; Poggioli G; Fuccio L; Morganti AG
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):572-580. PubMed ID: 36127416
[TBL] [Abstract][Full Text] [Related]
20. Prognostic utility of serial
Fernando S; Lin M; Pham TT; Chong S; Ip E; Wong K; Chua W; Ng W; Lin P; Lim S
Br J Radiol; 2020 Jan; 93(1105):20190455. PubMed ID: 31617737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]